Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Deaths of paid ...
As the NHS marks a year of using UK‑donated plasma, one London patient says the treatment has stabilised his symptoms and given him back his independence. Since 2011, Niall Whatley from Brixton in ...
SUNNYVALE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. All establishments ...